Background /Aims: Propofol is widely used for sedation during upper endoscopy; however, oversedation may increase the risk of complications, including aspiration pneumonia. This study aimed to determine whether propofol overdose is a risk factor for suspected postendoscopic infectious fever (SPIF).
Methods We retrospectively analyzed 1,474 in-patients who underwent upper endoscopy at Inha University Hospital between October 2021 and October 2022. After excluding 400 patients who received interventional procedures, SPIF was defined as new-onset fever (≥38 °C) within three days post-endoscopy with at least one of the following: intravenous antibiotic initiation, leukocytosis (white blood cell≥10,000/mm³), positive blood or sputum cultures, or pneumonia on chest X-ray. The risk factors assessed included comorbidities, sedative type and dosage, procedure duration, and endoscopist’s experience.
Results New-onset fever occurred in 40 patients (3.7%), with 20 (1.9%) meeting SPIF criteria. Multivariable analysis showed propofol overdose (>2.2 mg/kg) significantly increased risks of new-onset fever (odds ratio [OR], 1.03; 95% confidence interval [CI], 1.00–1.06; p=0.023) and SPIF (OR, 1.04; 95% CI, 1.00–1.04; p=0.034). Dementia (OR, 1.11, p<0.001) and prolonged procedure (>5 minutes; OR, 1.01; p=0.012) were also risk factors for SPIF.
Conclusions Propofol overdose significantly increases the risk of SPIF. Careful sedation management is essential, especially for patients with dementia or prolonged procedures.
Background /Aims: Helicobacter pylori infection-negative gastric cancer (HPNGC) has not been systematically investigated in consecutive patients. Hence, this study aimed to investigate the clinicopathological and endoscopic features of HPNGC.
Methods This single-center retrospective study selected participants from patients with gastric cancer who were treated at the Fukuoka University Chikushi Hospital between January 2013 and December 2021. Only patients diagnosed with HPNGC were enrolled, and their clinicopathological and endoscopic features were analyzed in detail.
Results The prevalence of HPNGC in the present study was 2.6% (54/2112). The types of HPNGC observed in each gastric region were as follows: advanced gastric cancer was observed in the cardia; gastric adenocarcinoma of fundic-gland differentiation, gastric adenocarcinoma of foveolar-type presenting with whitish elevation and raspberry-like foveolar-type gastric adenocarcinoma, gastric adenocarcinoma arising in polyposis, and gastric adenocarcinoma with autoimmune gastritis were observed in the fundic gland region ranging from the gastric fornix to the gastric body; signet-ring cell carcinoma was observed in the gastric-pyloric transition region ranging from the lower gastric body to the gastric angle; and well-differentiated tubular adenocarcinoma with low-grade atypia was observed in the antrum.
Conclusions This study revealed that tumors from each gastric region exhibited distinct macroscopic and histological types in HPNGC.
Citations
Citations to this article as recorded by
Incarceration of the Afferent Loop into the Sutured Closed Mesenteric Defect after Gastrectomy Followed by Billroth-II Reconstruction for Gastric Cancer: Two Case Reports Kiyotomi Maruyama, Tadaaki Shimizu, Kou Shimada, Arano Makino, Natsuhiro Morita, Tasuku Kawaguchi, Takahiro Amano, Tomoki Shirota, Kuniyuki Gomi, Motohiro Mihara Surgical Case Reports.2025; 11(1): n/a. CrossRef
Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional Study Edith Lahner, Bruno Annibale, Emanuele Dilaghi, Cristina Luciano Millado, Marco Vincenzo Lenti, Antonio Di Sabatino, Emanuela Miceli, Sara Massironi, Nicola Zucchini, Renato Cannizzaro, Stefano Realdon, Giuseppe Losurdo, Antonia Valeria Borraccino, Elisa Clinical and Translational Gastroenterology.2025; 16(8): e00862. CrossRef
Endoscopic submucosal dissection in Helicobacter pylori-negative early gastric adenocarcinoma with diffuse large B-cell lymphoma: a two-case report and literature review Bo Zhang, Xue-Guo Sun, Qing-Juan He, Li Chen, Ti-Dong Shan Discover Oncology.2025;[Epub] CrossRef
Helicobacter pylori-Mediated Injury: The Hidden Path to Gastric Hemorrhage and Neoplasia Sabrina-Nicoleta Munteanu, Ana-Maria Filip, Patrick-Lazăr-Dominik Chiciudean, Monica Pantea, Simona Mocan, Anca Elena Negovan Microorganisms.2025; 13(10): 2392. CrossRef
Is your endoscopist qualified enough to detect Helicobacter pylori-naive status? Sun-Young Lee Clinical Endoscopy.2024; 57(4): 466. CrossRef
Endoscopic retrograde cholangiopancreatography (ERCP) plays a crucial role in the management of pancreaticobiliary disorders. Although the ERCP technique has been refined over the past five decades, it remains one of the endoscopic procedures with the highest rate of complications. Risk factors for ERCP-related complications are broadly classified into patient-, procedure-, and operator-related risk factors. Although non-modifiable, patient-related risk factors allow for the closer monitoring and instatement of preventive measures. Post-ERCP pancreatitis is the most common complication of ERCP. Risk reduction strategies include intravenous hydration, rectal nonsteroidal anti-inflammatory drugs, and pancreatic stent placement in selected patients. Perforation is associated with significant morbidity and mortality, and prompt recognition and treatment of ERCP-related perforations are key to ensuring good clinical outcomes. Endoscopy plays an expanding role in the treatment of perforations. Specific management strategies depend on the location of the perforation and the patient’s clinical status. The risk of post-ERCP bleeding can be attenuated by preprocedural optimization and adoption of intra-procedural techniques. Endoscopic measures are the mainstay of management for post-ERCP bleeding. Escalation to angioembolization or surgery may be required for refractory bleeding. Post-ERCP cholangitis can be reduced with antibiotic prophylaxis in high risk patients. Bile culture-directed therapy plays an important role in antimicrobial treatment.
Citations
Citations to this article as recorded by
Global research trends on endoscopic bariatric surgery: bibliometric analysis over past 2 decades Linjing Li, Kun Zhou, Hang Yin, Rongrong Bi, Lei Wang Updates in Surgery.2026;[Epub] CrossRef
Is the Success Rate of Endoscopic Retrograde Cholangiopancreatography (ERCP) ± Sphincterotomy Done for Bile Duct Stones Optimal? Ciprani Debora, Amar Hoda, Abusharar Majd, Lopes Trisha, Karmarkar Rahi, Almadi Ahmed, Aroori Somaiah Digestive Diseases and Sciences.2026; 71(2): 672. CrossRef
rs928508 of miR-30c-5p is Associated With the Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis Yunyun Sun, Xia Li, Liang Chen, Jun Zhang Pancreas.2026; 55(1): e112. CrossRef
Radiomics analysis based on MRCP for predicting post-ERCP pancreatitis in patients with common bile duct stones Sheng Chen, Yiyi Jin, Yonghui Wu, Chaotao Tang, Youxiang Chen Surgical Endoscopy.2026; 40(3): 2447. CrossRef
An interpretable machine learning model for predicting the risk of post-endoscopic retrograde cholangiopancreatography complications in elderly patients with choledocholithiasis Guanjun Zhang, Ke Meng, Yaqi Zhai, Min Zhu, Yuming Han, Mingyang Li Saudi Journal of Gastroenterology.2026; 32(3): 228. CrossRef
Nationwide Survey on Endoscopic Papillectomy for Ampullary Adenoma: Current Practices and Variability Hyung Ku Chon, Ik Hyun Jo, Sungjo Bang, Kihyun Ryu, Dong Wook Lee, Eaum Seok Lee, Yoon Suk Lee, Jonghyun Lee, Huapyong Kang, Tae Joo Jeon, Chang Hwan Park Gut and Liver.2026; 20(2): 326. CrossRef
Dissolving the problem: Biodegradable stents as a value-driven strategy for post-ERCP pancreatitis prophylaxis in high-risk patients Clement Wu, Venkata Akshintala Pancreatology.2026; 26(3): 337. CrossRef
Topical tranexamic acid and sucralfate prevent delayed bleeding after endoscopic sphincterotomy: a randomized controlled trial (with video) Hsueh-Chien Chiang, Jui-Wen Kang, Wei-Lun Chang, Tzu-Ling Kuo, Chien-Ming Chiang, Juei-Seng Wu, Po-Jun Chen, Chiao-Hsiung Chuang, Chiung-Yu Chen, Xi-Zhang Lin, Meng-Ying Lin Therapeutic Advances in Gastroenterology.2026;[Epub] CrossRef
Ускладнення лікувальної ендоскопічної ретроградної холангіопанкреатографії у хворих на холедохолітіаз V. A. Katsal, M. A. Hudz, T. V. Formanchuk, V. V. Balabuieva, V. A. Maliuha, M. V. Kushkova Reports of Vinnytsia National Medical University.2026; 30(1): 73. CrossRef
Clinical predictive modeling for post-ERCP cholangitis in biliary stricture patients Bensong Duan, Weixin Ye, Yuping Shi, Suhong Yi, Dadong Wan, Yang Jiang, Liqian Xuan, Jiangfeng Hu Frontiers in Medicine.2026;[Epub] CrossRef
Comparison of the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with and without diabetes: a meta-analysis Fang Jia, Fujing Lv, Shutian Zhang Surgical Endoscopy.2025; 39(2): 807. CrossRef
Small common bile duct - the risk factor for post-ercp pancreatitis in patients with choledocholithiasis Ivan Mamontov, Tamara Tamm, Kostiantyn Kramarenko, Dmytro Ryabushchenko, Dmytro Sytnik, Samer Dghaili Wiadomości Lekarskie.2025; 77(12): 2388. CrossRef
Multidisciplinary Therapeutic Approaches to Pancreatic Cancer According to the Resectability Status Aurelio Mauro, Carlotta Faverio, Leonardo Brizzi, Stefano Mazza, Davide Scalvini, Daniele Alfieri, Alessandro Cappellini, Fabio Chicco, Carlo Ciccioli, Claudia Delogu, Marco Bardone, Anna Gallotti, Anna Pagani, Francesca Torello Viera, Andrea Anderloni Journal of Clinical Medicine.2025; 14(4): 1167. CrossRef
Effect of periampullary diverticulum morphology on ERCP cannulation and clinical results Yavuz Cagir, Muhammed Bahaddin Durak, Cem Simsek, Ilhami Yuksel Scandinavian Journal of Gastroenterology.2025; 60(4): 292. CrossRef
A Report of a Rare Case of Choledocholithiasis Complicated by Proximal Basket Rod Rupture Requiring Surgical Intervention Alexandre Gomes Cureus.2025;[Epub] CrossRef
Development of a Checklist for Evaluating Pancreatobiliary Endoscopy Training Facilities and Educational Programs Hyung Ku Chon, Sung-Jo Bang, Eaum Seok Lee, Tae Ju Jeon, Chang Hwan Park The Korean Journal of Pancreas and Biliary Tract.2025; 30(2): 93. CrossRef
Burden and cost of post–endoscopic retrograde cholangiopancreatography pancreatitis among commercially insured people undergoing endoscopic retrograde cholangiopancreatography Anna Tavakkoli, Kandice A. Kapinos, B. Joseph Elmunzer, Richard S. Kwon, David M. Troendle, Song Zhang, Amit G. Singal Gastrointestinal Endoscopy.2025; 102(5): 692. CrossRef
Preprocedural score system for post-ERCP pancreatitis risk stratification in patients with billiary obstruction I.М. Mamontov, D.D. Riabushchenko, Т.І. Tamm, K.О. Kramarenko, S. Dghaili, V.V. Nepomniashchyi Український радіологічний та онкологічний журнал.2025; 33(1): 9. CrossRef
Prevalence and Characteristics of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Complications in Patients With Biliopancreatic Disorders: A Retrospective Study Jose Luis Vallejo Romero, Yazmin Cardenas Ramos, Floricel Olimpia Villegas Amador, Sandra Allison Barrueta Orive, Erick Mauricio Aldana Carbajal, Maria Guadalupe Ramirez Lugo, Karen Andrea Martinez Martinez, Diana Laura Montiel Covarrubias, Luis Eduardo N Cureus.2025;[Epub] CrossRef
Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Complications: A Systematic Review of Microbial Patterns, Incidence, Risk Factors, and Management Strategies in Contemporary Practice Anmar Al-Kabban, Fadi M Al-Kabban, Ola Obaid Cureus.2025;[Epub] CrossRef
A Comprehensive Review of Digestive Endoscopy-Associated Infections: Bacterial Pathogens, Host Susceptibility, and the Impact of Viral Hepatitis Deniz Günșahin, Vasile Șandru, Gabriel Constantinescu, Mădălina Ilie, Teodor Cabel, Ramona Ștefania Popescu, Bogdan Silviu Ungureanu, Victor Daniel Miron, Gheorghe G. Balan, Diana Cotigă, Bogdan Miutescu, Gülşen Özkaya Şahin, Oana Săndulescu Microorganisms.2025; 13(9): 2128. CrossRef
Complications and expected imaging findings after endoscopic retrograde cholangiopancreatography Mehmet Simsar, Yesim Yekta Yuruk, Olgun Sahin, Hilal Sahin World Journal of Radiology.2025;[Epub] CrossRef
Efficacy and safety of cap-assisted colonoscopy in endoscopic retrograde cholangiopancreatography for patients after Billroth II gastrectomy Chun-Xiao Hu, Sheng-Yue Zhou, Xiao-Hua Ye World Chinese Journal of Digestology.2025; 33(9): 707. CrossRef
Efficacy of hydration combined with rectal non-steroidal anti-inflammatory drugs (NSAIDs) versus NSAIDs alone for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis of randomized contr Huimin Li, Changfeng Miao, Wei Fang, Yuan Deng, Xiong Li, Ting Du, Hongwei Tian BMC Gastroenterology.2025;[Epub] CrossRef
Comparison of clinical outcomes for single- and double-balloon enteroscope-assisted endoscopic retrograde cholangiopancreatography in patients with surgically altered anatomy Sung Yong Han, Min Jae Yang, Kyong Joo Lee, Jonghyun Lee, Se Woo Park World Journal of Gastroenterology.2025;[Epub] CrossRef
Combination use of intravenous ketamine-midazolam as a sedative agent in endoscopic retrograde cholangiopancreatography: a randomized control trial Rajdave Singh Sadu Singh, Azlanudin Azman, Jegan Thanabalan, Chik Ian, Boo Han Sin, Razman Jarmin, Fahrol Fahmy Jaafar Scientific Reports.2025;[Epub] CrossRef
Identifying high-risk patients having ERCP as a day surgery with an online prediction platform: Multicohort validation of a machine learning model Boru Jin, Yi Wang, Xu Zhang, Jinyu Zhao, Wangping He, Kecheng Jin, Zhen Liu, Ruyang Zhong, Yuhu Ma, Chunlu Dong, Yanyan Lin, Xiaoliang Zhu, Kexiang Zhu, Lei Zhang, Ping Yue, Shuyan Li, Jinqiu Yuan, Xun Li, Wenbo Meng Endoscopy International Open.2025;[Epub] CrossRef
Prevention of post-ERCP complications Lotfi Triki, Andrea Tringali, Marianna Arvanitakis, Tommaso Schepis Best Practice & Research Clinical Gastroenterology.2024; 69: 101906. CrossRef
International Digestive Endoscopy Network consensus on the management of antithrombotic agents in patients undergoing gastrointestinal endoscopy Seung Joo Kang, Chung Hyun Tae, Chang Seok Bang, Cheol Min Shin, Young-Hoon Jeong, Miyoung Choi, Joo Ha Hwang, Yutaka Saito, Philip Wai Yan Chiu, Rungsun Rerknimitr, Christopher Khor, Vu Van Khien, Kee Don Choi, Ki-Nam Shim, Geun Am Song, Oh Young Lee Clinical Endoscopy.2024; 57(2): 141. CrossRef
Double-guidewire technique for selective biliary cannulation does not increase the rate of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with naïve papilla Han Taek Jeong, June Hwa Bae, Ho Gak Kim, Jimin Han Clinical Endoscopy.2024; 57(2): 226. CrossRef
Computed tomography-based prediction of pancreatitis following biliary metal stent placement with the convolutional neural network Tsuyoshi Hamada, Koichiro Yasaka, Yousuke Nakai, Rintaro Fukuda, Ryunosuke Hakuta, Kazunaga Ishigaki, Sachiko Kanai, Kensaku Noguchi, Hiroki Oyama, Tomotaka Saito, Tatsuya Sato, Tatsunori Suzuki, Naminatsu Takahara, Hiroyuki Isayama, Osamu Abe, Mitsuhiro Endoscopy International Open.2024; 12(06): E772. CrossRef
IDEN Consensus on Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy Seung Joo Kang, Chung Hyun Tae, Chang Seok Bang, Cheol Min Shin, Young-Hoon Jeong, Miyoung Choi, Joo Ha Hwang, Yutaka Saito, Philip Wai Yan Chiu, Rungsun Rerknimitr, Christopher Khor, Vu Van Khien, Kee Don Choi, Ki-Nam Shim, Geun Am Song, Oh Young Lee The Korean Journal of Gastroenterology.2024; 83(6): 217. CrossRef
International Digestive Endoscopy Network Consensus on the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy Seung Joo Kang, Chung Hyun Tae, Chang Seok Bang, Cheol Min Shin, Young-Hoon Jeong, Miyoung Choi, Joo Ha Hwang, Yutaka Saito, Philip Wai Yan Chiu, Rungsun Rerknimitr, Christopher Khor, Vu Van Khien, Kee Don Choi, Ki-Nam Shim, Geun Am Song, Oh Young Lee Gut and Liver.2024; 18(5): 764. CrossRef
Risk factors for acute pancreatitis after endoscopic retrograde cholangiopancreatography: a retrospective single-center study I.М. Mamontov, D.D. Rjabushhenko, Т.І. Tamm, К.О. Kramarenko, V.V. Nepomniashchyi, A.T. Ustinov Український радіологічний та онкологічний журнал.2024; 32(3): 287. CrossRef
Could assessment of genetic susceptibility be an effective solution to prevent pancreatitis from occurring after endoscopic retrograde cholangiopancreatography? Jae Min Lee The Korean Journal of Internal Medicine.2023; 38(6): 783. CrossRef
Epifanio Silvino do Monte Junior, Marcos Eduardo Lera dos Santos, Igor Braga Ribeiro, Gustavo de Oliveira Luz, Elisa Ryoka Baba, Bruno Salomão Hirsch, Mateus Pereira Funari, Eduardo Guimarães Hourneaux de Moura
Clin Endosc 2020;53(6):746-749. Published online November 19, 2020
The novel coronavirus disease (COVID-19) quickly spread to all continents. However, data regarding all the signs and symptoms of COVID-19 are insufficient. Patients with COVID-19 might present higher susceptibility to fungal coinfections. Mucormycosis is a rare and often life-threatening fungal disease characterized by vascular invasion by hyphae, resulting in thrombosis and necrosis. This is the first case report of mucormycosis in a COVID-19 patient. An 86-year-old male patient was admitted to the emergency room with acute diarrhea, cough, dyspnea, and fever from 5 days prior. Blood tests revealed a hemoglobin level of 14.3 mg/dL. Five days following the admission, the patient presented with melena and a hemoglobin level of 5.6 mg/dL. A transfusion of three units of red blood cells was required. Esophagogastroduodenoscopy revealed two giant gastric ulcers with necrotic debris and a deep hemorrhagic base without active bleeding. Furthermore, biopsies confirmed mucormycosis. Despite intensive care, the patient died 36 hours after the esophagogastroduodenoscopy.
Citations
Citations to this article as recorded by
COVID-19 associated mucormycosis and their therapeutics Bhaswati Chatterjee, Suman S. Thakur Heliyon.2026; 12(4): e44661. CrossRef
Rare Vascular Diseases: Scoping Review with ☸️SAIMSARA
Intra-abdominal Mucormycosis in an Immunocompetent Host: A Rare Presentation and Literature Review Sevag Hamamah, Nupur Savalia, Faizi Hai Cureus.2025;[Epub] CrossRef
Gastrointestinal and Intra-Abdominal Mucormycosis in Non-Haematological Patients—A Comprehensive Review Benoît Henry, Alain Lefevre Utile, Stephane Jaureguiberry, Adela Angoulvant Journal of Fungi.2025; 11(4): 298. CrossRef
Mucormycosis and COVID-19: Unraveling the Interplay of Fungal Infection in a Global Health Crisis: An Overview Ali Moheb-Alian, Ali Akbari, Saghi Nooraei, Howra Bahrulolum, Zoheir Mohammadian Farsani, Negin Mokhtari, Mozhdeh Sadat Ebadi, Arezoo Mohammadian Farsani, Seyedmoein Khatami, Mohammadmahdi Esmaeili, Zahra Keykhaee, Mohammad Hossein Heydargoy, Zahra Rafiei Infectious Disorders - Drug Targets.2025;[Epub] CrossRef
Uncovering the Predisposing Factors of Mucormycosis: Insights from Systematic Review Ramya Ravindhiran, Kumarappan Chidambaram, Anandalakshmi Subramanian, Suresh Velayutham, Mohankumar Ramar, Kavitha Dhandapani Indian Journal of Microbiology.2025;[Epub] CrossRef
Gastrointestinal mucormycosis associated with leptospirosis: should we be concerned during major floods? Mariane Taborda, Juliana Possatto Fernandes Takahashi, Jessica de Brito Ferreira Nascimento, Julia Ferreira Mari, Vítor Falcão de Oliveira, Adriana Satie Gonçalves Kono Magri, Ana Catharina de Seixas Santos Nastri, Marcello Mihailenko Chaves Magri Revista do Instituto de Medicina Tropical de São Paulo.2025;[Epub] CrossRef
Mucormycosis as a complication of COVID-19: connection with immunodeficiency states, features of the course and prevention O.V. Bobrova, N.H. Mikhanovska, N.H. Tsukor Karazin Journal of Immunology.2025; (15): 8. CrossRef
The potential for rapid antigen testing for mucormycosis in the context of COVID-19 Christopher R. Thornton Expert Review of Molecular Diagnostics.2024; 24(3): 161. CrossRef
A New Proposed Combined CT and MRI Staging System for Covid-19-Associated Rhino-Orbito-Cerebral Fungal Infection: A Multi-center Study with Pathological Correlation Noha Yahia Ebaid, Haitham Foda, Doaa Khedr Mohamed Khedr, Ahmed Ebeed, Mahmoud Ahmed Ebada, Rabab Mohamed Abdelhay, Ali Awad, Amany Abd Al Badea, Basma Hamed Ibrahim, Emad Hassan Emara Academic Radiology.2024; 31(3): 1055. CrossRef
Development of a Machine Learning Model to Predict Risk of Development of COVID-19-Associated Mucormycosis Rajashri Patil, Sahjid Mukhida, Jyoti Ajagunde, Uzair Khan, Sameena Khan, Nageswari Gandham, Chanda Vyawhare, Nikunja K Das, Shahzad Mirza Future Microbiology.2024; 19(4): 297. CrossRef
COVID-19 Second Wave with Mucormycosis, a Deadly Combination: A Systemic Review Neetu Jain, Seema Bhadauria Biomedical and Biotechnology Research Journal.2024; 8(1): 13. CrossRef
Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens C Orla Morrissey, Hannah Yejin Kim, Katherine Garnham, Aiken Dao, Arunaloke Chakrabarti, John R Perfect, Ana Alastruey-Izquierdo, Thomas S Harrison, Felix Bongomin, Marcelo Galas, Siswanto Siswanto, Daniel Argaw Dagne, Felipe Roitberg, Valeria Gigante, Ha Medical Mycology.2024;[Epub] CrossRef
Fungal Infection in Upper Gastrointestinal Tract Ayoung Lee, Sung Woo Jung, Jung Mogg Kim The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2024; 24(2): 136. CrossRef
COVID-19 as a critical risk factor for osteonecrosis of the jaw: diagnostic challenge and surgical treatment Antonio Romano, Roberta Gasparro, Maria Domenica Campana, Biagio Pinchera, Rosa Maria Di Crescenzo, Donatella Del Guercio, Marco Sarcinella, Marco Tatullo, Gilberto Sammartino Current Problems in Surgery.2024; 61(9): 101555. CrossRef
Hospitalized COVID-19 Patients with Urinary Tract Infection in Iran: Candida Species Distribution and Antifungal Susceptibility Patterns Zeinab Soleimani Shiyadeh, Shirin Farahyar, Laleh Vahedi Larijani, Justin Beardsley, Noura Nouri, Shahram Mahmoudi, Shahla Roudbar Mohammadi, Célia Fortuna Rodrigues, Maryam Roudbary Antibiotics.2024; 13(7): 633. CrossRef
Emergence of mucormycosis in post-COVID infections in tertiary care hospital Warangal Goteti V. Padmaja, Shanigarapu R. Kumar Journal of Dr. NTR University of Health Sciences.2024; 13(2): 83. CrossRef
The underlying factors of occurrence of Mucormycosis in post-COVID-19 patients – A meta-analysis of case histories Srishti Sen, Shubhangi Tiwari, Sinjini Banerjee, Mihir Ghosh, Boudhayan Bandyopadhyay Journal of Experimental Biology and Agricultural Sciences.2024; 12(3): 457. CrossRef
Functional characterization of two survival factor 1 genes in
Mucor lusitanicus
Olivér Jáger, Csilla Szebenyi, Tammam Khaliefeh Siliman Abu Saleem, Anna Molnár, Vanda Kovács, Karina Kiss, Mónika Homa, Bernadett Vágó, Sándor Kiss-Vetráb, Mónika Varga, Rita Sinka, Csaba Vágvölgyi, Gábor Nagy, Tamás Papp, Renato Kovacs Microbiology Spectrum.2024;[Epub] CrossRef
Mucormycosis: An Emerging Fungal Infection in the COVID-19 Pandemic Parisa Saberi-Hasanabai, Milad Esmaeilzadeh Farmad, Ramin Ataee Journal of Medical Microbiology and Infectious Diseases.2024; 12(2): 84. CrossRef
Epidemiology, pathogenesis, clinical characteristics, and treatment of mucormycosis: a review Mei Liang, Jian Xu, Yanan Luo, Junyan Qu Annals of Medicine.2024;[Epub] CrossRef
Effectiveness of hyperbaric oxygen therapy in the management of COVID-19-associated mucormycosis Sandhya Pandey, Vijay Kumar, Ravi Kumar, Brijesh Mishra, Anshu Singh, Gowtham Reddy Medical Gas Research.2024; 14(2): 87. CrossRef
Gastric Mucormycosis: A Systematic Review with Metadata Ayman M. Mustafa, Yousif M. Mahmood, Ali H. Hasan, Hoshmand R. Asaad, Dana T. Gharib, Karokh F. Hama Hussein, Karzan M. Hasan, Deari A. Ismaeil, Dilan S. Hiwa, Rawa M. Ali, Khanda A. Anwar, Diyar A. Omar, Mohammed Q. Mustafa Barw Medical Journal.2024;[Epub] CrossRef
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19 Shrey Dwivedi, Princy Choudhary, Ayushi Gupta, Sangeeta Singh Critical Reviews in Microbiology.2023; 49(3): 318. CrossRef
Magnetic resonance imaging spectrum of COVID-associated rhino-orbital-cerebral mucormycosis and assessment of anatomical severity Ishan Kumar, Ashish Verma, Jyoti Dangwal, Pramod Kumar Singh, Ram Chandra Shukla, Jaya Chakravarty The Neuroradiology Journal.2023; 36(4): 404. CrossRef
Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review Bharti Sharma, Skarma Nonzom Current Microbiology.2023;[Epub] CrossRef
Mucormycosis: A hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents Mohd Kamil Hussain, Shaista Ahmed, Andleeb Khan, Arif Jamal Siddiqui, Shahnaaz Khatoon, Sadaf Jahan European Journal of Medicinal Chemistry.2023; 246: 115010. CrossRef
cotH
Genes Are Necessary for Normal Spore Formation and Virulence in
Mucor lusitanicus
Csilla Szebenyi, Yiyou Gu, Teclegiorgis Gebremariam, Sándor Kocsubé, Sándor Kiss-Vetráb, Olivér Jáger, Roland Patai, Krisztina Spisák, Rita Sinka, Ulrike Binder, Mónika Homa, Csaba Vágvölgyi, Ashraf S. Ibrahim, Gábor Nagy, Tamás Papp, Anuradha Chowdhary mBio.2023;[Epub] CrossRef
Post COVID-19: Risk Factors, Prevention, and Management of Black
Fungus Aimen Salman, Suneela Dhaneshwar, Shaik Shafiulla Anti-Infective Agents.2023; 21(1): 39. CrossRef
Surge of mucormycosis during the COVID-19 pandemic Paulami Dam, Marlon H. Cardoso, Sukhendu Mandal, Octávio L. Franco, Pınar Sağıroğlu, Osman Ahmet Polat, Kerem Kokoglu, Rittick Mondal, Amit Kumar Mandal, Ismail Ocsoy Travel Medicine and Infectious Disease.2023; 52: 102557. CrossRef
COVID-19 and Mucormycosis of Orofacial Region: A Scoping Review Abhishek Banerjee, Moumalini Das, Pooja Verma, Abhishek Chatterjee, Karthikeyan Ramalingam, Kumar Chandan Srivastava Cureus.2023;[Epub] CrossRef
Case Reports on Black Fungus of the Gastrointestinal Tract: A New Complication in COVID-19 Patients Sachin Arora, Ashish Singh, Pallavi Prasad, Rahul, Rajneesh Singh The Korean Journal of Gastroenterology.2023; 81(5): 221. CrossRef
Galangin for COVID-19 and Mucormycosis co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and Mucormycosis Md. Imran Hasan, Md. Arju Hossain, Md Habibur Rahman, Md Sohel, Asif Ahsan, Md. Sadat Hossain Soikot, Md. Nazrul Islam, Mohammad Ruhul Amin, Deepak Kumar Jain Network Modeling Analysis in Health Informatics and Bioinformatics.2023;[Epub] CrossRef
Opportunistic Fungal Invasion in COVID-19 Pandemic: A Critical Review in Diagnosis and Management Abhishek Sharma, Gulnaz Bano, Abdul Malik, Yuman Rasool, Samrina Manzar, Tarun Singh, Manish Maity Avicenna Journal of Medicine.2023; 13(03): 131. CrossRef
Effect of antifungal drugs against mucormycosis and impact on human health Shivangi Giri, Sujata Sharma, Kumud Kant Awasthi, Lata Shahani Materials Today: Proceedings.2023; 95: 43. CrossRef
Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review Pragati Upadhayay, Keshav Bansal, Ahsas Goyal Current Pharmaceutical Biotechnology.2023; 24(13): 1645. CrossRef
View of mucormycosis during the era of COVID-19 infection: A cross-sectional study Ossama M. Zakaria, Dana W. Alkuwaity Journal of Family Medicine and Primary Care.2023; 12(11): 2608. CrossRef
An Update on COVID‐19 Associated Mucormycosis Characteristics, Risk Factors, and Outcomes: a Systematic Review and Meta-Analysis Kazem Khiabani, Mohammad Hosein Amirzade-Iranaq, Hanie Ahmadi Current Fungal Infection Reports.2023; 17(4): 282. CrossRef
CT Findings of COVID-19–associated Pulmonary Mucormycosis: A Case Series and Literature Review Mandeep Garg, Nidhi Prabhakar, Valliappan Muthu, Shameema Farookh, Harsimran Kaur, Vikas Suri, Ritesh Agarwal Radiology.2022; 302(1): 214. CrossRef
Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins Karthika Pushparaj, Haripriya Kuchi Bhotla, Vijaya Anand Arumugam, Manikantan Pappusamy, Murugesh Easwaran, Wen-Chao Liu, Utthapon Issara, Kannan R.R. Rengasamy, Arun Meyyazhagan, Balamuralikrishnan Balasubramanian Science of The Total Environment.2022; 805: 150355. CrossRef
Mucormycosis: A Case Series of Patients Admitted in Non-COVID-19 Intensive Care Unit of a Tertiary Care Center during the Second Wave Nikhil Kothari, Amit Goyal, Ankur Sharma, Shilpa Goyal, Pradeep K Bhatia, Sangam Yadav Indian Journal of Critical Care Medicine.2022; 25(10): 1193. CrossRef
A systematic review on SARS‐CoV‐2‐associated fungal coinfections Shringika Soni, Ramesh Namdeo Pudake, Utkarsh Jain, Nidhi Chauhan Journal of Medical Virology.2022; 94(1): 99. CrossRef
Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital Taha K. Alloush, Osama Mansour, Adel T. Alloush, Tamer Roushdy, Eman Hamid, Mahmoud El-Shamy, Hossam M. Shokri Neurological Sciences.2022; 43(2): 799. CrossRef
Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India Twinkle Choksi, Anamika Agrawal, Purva Date, Darshana Rathod, Anuja Gharat, Avinash Ingole, Bhushan Chaudhari, Nitin Pawar JAMA Ophthalmology.2022; 140(1): 66. CrossRef
Using artificial intelligence-based models to predict the risk of mucormycosis among COVID-19 survivors: An experience from a public hospital in India Shabbir Syed-Abdul, A. Shoban Babu, Raja Shekhar Bellamkonda, Ramaiah Itumalla, GVRK Acharyulu, Surya Krishnamurthy, Y. Venkat Santosh Ramana, Naresh Mogilicharla, Shwetambara Malwade, Yu-Chuan Li Journal of Infection.2022; 84(3): 351. CrossRef
Bilateral Renal Mucor Mycosis Presenting as Anuria in a Covid 19 Recovered Patient: A Case Report and Review of Literature Surya Prakash Vaddi, Seshu Mohan Khetavath, Dilip M. Babu, Nagarjuna Maturu, Bhulaxmi, Swathi, Krithika Mohan, Datta Prasad M, Jawahar B, Rajesh Reddy KRV Urology.2022; 161: 12. CrossRef
Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients Kerri Basile, Catriona Halliday, Jen Kok, Sharon C-A. Chen Journal of Fungi.2022; 8(1): 58. CrossRef
Gastrointestinal mucormycosis: A periodic systematic review of case reports from 2015 to 2021 Mojtaba Didehdar, Zahra chegini, Alireza Moradabadi, Ali Arash Anoushirvani, Seidamir Pasha Tabaeian, Milad Yousefimashouf, Aref Shariati Microbial Pathogenesis.2022; 163: 105388. CrossRef
Gastrointestinal Mucormycosis: A Challenge during COVID-19 Pandemic Jagdish Chander Journal of Gastrointestinal Infections.2022; 11(1): 30. CrossRef
COVID-19 associated mucormycosis – An emerging threat Chien-Ming Chao, Chih-Cheng Lai, Wen-Liang Yu Journal of Microbiology, Immunology and Infection.2022; 55(2): 183. CrossRef
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries Martin Hoenigl, Danila Seidel, Agostinho Carvalho, Shivaprakash M Rudramurthy, Amir Arastehfar, Jean-Pierre Gangneux, Nosheen Nasir, Alexandro Bonifaz, Javier Araiza, Nikolai Klimko, Alexandra Serris, Katrien Lagrou, Jacques F Meis, Oliver A Cornely, John The Lancet Microbe.2022; 3(7): e543. CrossRef
Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India Reshma P. Chavan, Shivraj M. Ingole, Hamna Abdul Nazir, Wilson V. Desai, Gajanan S. Kanchewad European Archives of Oto-Rhino-Laryngology.2022; 279(6): 3201. CrossRef
Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, Khaled Alhosaini, Mohammad Owais, Aijaz Ahmad Journal of Infection and Public Health.2022; 15(4): 466. CrossRef
COVID19 associated mucormycosis: A review Priyadharsini R. Palanisamy, Dhivya Elango Journal of Family Medicine and Primary Care.2022; 11(2): 418. CrossRef
Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic Ayushi Sharma, Anjana Goel Folia Microbiologica.2022; 67(3): 363. CrossRef
Retracted: Mucormycosis infection in patients with COVID‐19: A systematic review SeyedAhmad SeyedAlinaghi, Amirali Karimi, Alireza Barzegary, Zahra Pashaei, Amir Masoud Afsahi, Sanam Alilou, Nazanin Janfaza, Alireza Shojaei, Fatemeh Afroughi, Parsa Mohammadi, Yasna Soleimani, Newsha Nazarian, Ava Amiri, Marcarious M. Tantuoyir, Shahra Health Science Reports.2022;[Epub] CrossRef
Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India Ameet Dravid, Reema Kashiva, Zafer Khan, Balasaheb Bande, Danish Memon, Aparna Kodre, Milind Mane, Vishal Pawar, Dattatraya Patil, Suraj Kalyani, Prathamesh Raut, Madhura Bapte, Charlotte Saldanha, Dinesh Chandak, Teerthagouda Patil, Sateesh Reddy, Krushn Mycoses.2022; 65(5): 526. CrossRef
Rhino-Orbital-Cerebral Mucormycosis in a Post-COVID-19 Patient from Peru Linda Ponce-Rosas, Jose Gonzales-Zamora, Nelson Diaz-Reyes, Oliver Alarco-Cadillo, Jorge Alave-Rosas, Mohd Adnan Case Reports in Infectious Diseases.2022; 2022: 1. CrossRef
Mucormycosis: A Lethal Disease Pawan N. Karwa, Jyoti K. Soundarmal, Pallavi S. Shinde, Swapna R. Jalde Asian Journal of Pharmacy and Technology.2022; : 41. CrossRef
An overview of COVID-19 related to fungal infections: what do we know after the first year of pandemic? R. G. Vitale, J. Afeltra, S. Seyedmousavi, S. L. Giudicessi, S. M. Romero Brazilian Journal of Microbiology.2022; 53(2): 759. CrossRef
Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India Deganta Ghosh, Sagardeep Dey, Himanko Chakraborty, Sneha Mukherjee, Ankita Halder, Akash Sarkar, Pallab Chakraborty, Rajdeep Ghosh, Joy Sarkar Clinical Epidemiology and Global Health.2022; 15: 101013. CrossRef
First Reported Cases of COVID-19-Associated Mucormycosis in Tunisia Rim Khemakhem, Ichrak Bougharriou, Nesrine Kallel, Anis Bafoun, Feten Mahmoudi, Samy Kammoun Electronic Journal of Medical and Dental Studies.2022; 12(1): em0097. CrossRef
Iranian patients co-infected with COVID-19 and mucormycosis: the most common predisposing factor, clinical outcomes, laboratory markers and diagnosis, and drug therapies Hamideh Molaei, Ehsan Shojaeefar, Eghlim Nemati, Leila Khedmat, Sayed Yousef Mojtahedi, Nematollah Jonaidi Jafari, Morteza Izadi, Behzad Einollahi Infectious Diseases.2022; 54(8): 600. CrossRef
COVID-19 and Plethora of Fungal Infections Reetu Kundu, Nidhi Singla Current Fungal Infection Reports.2022; 16(2): 47. CrossRef
A Comprehensive Review on the Management of COVID-19-Associated Mucormycosis (CAM): The New Basics Divyam Girdhar, Ekta Manocha BioMed.2022; 2(2): 181. CrossRef
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis Laura C. García-Carnero, Héctor M. Mora-Montes Journal of Fungi.2022; 8(5): 445. CrossRef
COVID-19-Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach? Marianna Domán, Krisztián Bányai Frontiers in Microbiology.2022;[Epub] CrossRef
Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives Yasasve Madhavan, Kadambari Vijay Sai, Dilip Kumar Shanmugam, Aashabharathi Manimaran, Karthigadevi Guruviah, Yugal Kishore Mohanta, Divyambika Catakapatri Venugopal, Tapan Kumar Mohanta, Nanaocha Sharma, Saravanan Muthupandian Journal of Clinical Medicine.2022; 11(13): 3620. CrossRef
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review Sima Sadat Seyedjavadi, Parmida Bagheri, Mohammad Javad Nasiri, Mehdi Razzaghi-Abyaneh, Mehdi Goudarzi Frontiers in Microbiology.2022;[Epub] CrossRef
COVID-19-associated fungal infections in Iran: A systematic review Tina Nazari, Fatemeh Sadeghi, Alireza Izadi, Setayesh Sameni, Shahram Mahmoudi, Felix Bongomin PLOS ONE.2022; 17(7): e0271333. CrossRef
Effect of Indoor Bioaerosols (Fungal) Exposure on the Health of Post-COVID-19 Patients and Possible Mitigation Strategies Yogesh Kumar Vishwakarma, Amrita Shahi, Ram Sharan Singh COVID.2022; 2(7): 940. CrossRef
Mucormycosis in patients with COVID-19 in Russia: the results of a prospective multi-center study S. N. Khostelidi, V. A. Zaytsev, S. A. Vartanyan, N. A. Nikitin, G. N. Evtukh, M. N. Gilalov, G. V. Portnov, A. A. Zubareva, I. B. Baranova, T. S. Bogomolova, Yu. L. Avdeenko, O. V. Shadrivova, E. A. Desyatik, E. V. Shagdileeva, Yu. V. Borzova, Yu. A. Kri Journal Infectology.2022; 14(2): 116. CrossRef
Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans Genna E. Davies, Christopher R. Thornton Journal of Fungi.2022; 8(7): 756. CrossRef
Mucormycosis co-infection in COVID-19 patients: An update Abdullah S. Alkhamiss, Ahmed A. Ahmed, Zafar Rasheed, Ruqaih Alghsham, Ali Shariq, Thamir Alsaeed, Sami A. Althwab, Suliman Alsagaby, Abdullah S. M. Aljohani, Fahad A. Alhumaydhi, Sharifa K. Alduraibi, Alaa K. Alduraibi, Homaidan T. Alhomaidan, Khaled S. Open Life Sciences.2022; 17(1): 917. CrossRef
COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic Pankaj Chandley, Priyanka Subba, Soma Rohatgi Vaccines.2022; 10(8): 1266. CrossRef
Antifungal therapy in the management of fungal secondary infections in COVID-19 patients: A systematic review and meta-analysis Sujit Kumar Sah, Atiqulla Shariff, Niharika Pathakamuri, Subramanian Ramaswamy, Madhan Ramesh, Krishna Undela, Malavalli Siddalingegowda Srikanth, Teggina Math Pramod Kumar, Joy Sturtevant PLOS ONE.2022; 17(7): e0271795. CrossRef
The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review Nahid Akhtar, Atif Khurshid Wani, Surya Kant Tripathi, Ajit Prakash, M. Amin-ul Mannan Current Research in Biotechnology.2022; 4: 337. CrossRef
Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis Vahid Reza Ostovan, Reza Tabrizi, Hanieh Bazrafshan, Zahra Bahrami, Hajar Khazraei, Samaneh Khazraei, Afshin Borhani-Haghighi, Mohsen Moghadami, Matthew Grant Current Fungal Infection Reports.2022; 16(4): 143. CrossRef
Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review Prodip Kumar Baral, Md. Abdul Aziz, Mohammad Safiqul Islam Health Science Reports.2022;[Epub] CrossRef
COVID-19 and Fungal infections: a double debacle Sara Mina, Hajar Yaakoub, Cédric Annweiler, Vincent Dubée, Nicolas Papon Microbes and Infection.2022; 24(8): 105039. CrossRef
Wave of Invasive Fungal Disease on the Shores of COVID-19: A Case Series of COVID-19 Associated Rhino-Orbital Fungal Rhinosinusitis and Literature Review Sandeep Trehan, Neena Chaudhary, Ashwin Bhasarkar Indian Journal of Otolaryngology and Head & Neck Surgery.2022; 74(S2): 3359. CrossRef
A Study of Rhino-Orbito-Cerebral Mucormycosis with COVID-19 Surendra Kumar, Harish Kumar, Manoj Mali, Babu Lal Meena Annals of African Medicine.2022; 21(4): 383. CrossRef
Is the production of reactive oxygen and nitrogen species by macrophages associated with better infectious control in female mice with experimentally disseminated and pulmonary mucormycosis? Amanda Ribeiro dos Santos, Thais Fernanda Fraga-Silva, Débora de Fátima Almeida-Donanzam, Angela Carolina Finatto, Camila Marchetti, Maria Izilda Andrade, Olavo Speranza de Arruda, Maria Sueli Parreira de Arruda, James Venturini, Michal A Olszewski PLOS ONE.2022; 17(12): e0270071. CrossRef
Mucormycosis, COVID-19 Pandemic and the Lessons Learnt Anila Varghese, Anita Upadhyay, Roy A. Daniel, Twinkle Sharma, M. Shyam Mohan, Balaji Susindran, Priyanka Singh, Chandrakant Lahariya Journal of Medical Evidence.2022; 3(3): 256. CrossRef
Gastritis enfisematosa secundaria a mucormicosis gástrica en paciente con COVID-19. Reporte de un caso Martín Islas Torres, Ana Laura Castillo Luna, José Juan Rodríguez Moreno, Valeria Priscilla Rendón Muñoz, José Gerardo Zamora Inzuna, Albert Antonio Ibarra Trejo Cirujano General.2022; 44(2): 87. CrossRef
Mucormycosis and COVID-19 Ankit Kaushik, Anamika Jaiswal, Hari S. Pandey, Paramjeet Singh Medical Journal of Dr. D.Y. Patil Vidyapeeth.2022; 15(Suppl 2): S163. CrossRef
A systematic review of mucormycosis cases in COVID-19: Is it an unholy trilogy of COVID-19, diabetes mellitus, and corticosteroids? Rajesh Kumar, Arup Kumar Misra, Siddhartha Dutta, Ajay Gupta, Bharat Kumar, Jaykaran Charan Journal of Family Medicine and Primary Care.2022; 11(6): 2573. CrossRef
A Fatal Case of Rhizopus azygosporus Pneumonia Following COVID-19 Anubhav Kanwar, Alex Jordan, Scott Olewiler, Kurt Wehberg, Michael Cortes, Brendan R. Jackson Journal of Fungi.2021; 7(3): 174. CrossRef
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis Kazem Ahmadikia, Seyed Jamal Hashemi, Sadegh Khodavaisy, Muhammad Ibrahim Getso, Neda Alijani, Hamid Badali, Hossein Mirhendi, Mohammadreza Salehi, Azin Tabari, Mojtaba Mohammadi Ardehali, Mohammad Kord, Emmanuel Roilides, Sassan Rezaie Mycoses.2021; 64(8): 798. CrossRef
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature Akshay Khatri, Kai-Ming Chang, Ilan Berlinrut, Frances Wallach Journal of Medical Mycology.2021; 31(2): 101125. CrossRef
Research and Management of Rare Diseases in the COVID-19 Pandemic Era: Challenges and Countermeasures Sanjana Fatema Chowdhury, Syed Muktadir Al Sium, Saeed Anwar Frontiers in Public Health.2021;[Epub] CrossRef
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India Awadhesh Kumar Singh, Ritu Singh, Shashank R. Joshi, Anoop Misra Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(4): 102146. CrossRef
Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India Hardeva Ram Nehara, Inder Puri, Vipin Singhal, Sunil IH, Bhagirath Ram Bishnoi, Pramendra Sirohi Indian Journal of Medical Microbiology.2021; 39(3): 380. CrossRef
COVID 19 infection and mucormycosis—a dangerously increasing combination Satvinder Singh Bakshi, Vinoth Kumar Kalidoss The Egyptian Journal of Otolaryngology.2021;[Epub] CrossRef
Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection Vidya Krishna, Jaymin Morjaria, Rona Jalandari, Fatima Omar, Sundeep Kaul IDCases.2021; 25: e01172. CrossRef
Does COVID 19 generate a milieu for propagation of mucormycosis? Deepak Pandiar, N. Siva Kumar, Rahul Anand, Mala Kamboj, Anjali Narwal, P.M. Shameena Medical Hypotheses.2021; 152: 110613. CrossRef
Mucormycosis associated with COVID‐19 in two kidney transplant patients Carolt Arana, Rafael E. Cuevas Ramírez, Marc Xipell, Joaquim Casals, Asunción Moreno, Sabina Herrera, Marta Bodro, Frederic Cofan, Fritz Diekmann, Núria Esforzado Transplant Infectious Disease.2021;[Epub] CrossRef
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs Alfonso J. Rodriguez-Morales, Ranjit Sah, Jose Millan-Oñate, Angel Gonzalez, Juan J. Montenegro-Idrogo, Sias Scherger, Carlos Franco-Paredes, Andrés F. Henao-Martínez Therapeutic Advances in Infectious Disease.2021;[Epub] CrossRef
COVID‐19‐associated mucormycosis: An updated systematic review of literature Rimesh Pal, Birgurman Singh, Sanjay Kumar Bhadada, Mainak Banerjee, Ranjitpal Singh Bhogal, Neemu Hage, Ashok Kumar Mycoses.2021; 64(12): 1452. CrossRef
Rare case of gastrointestinal mucormycosis with colonic perforation in an immunocompetent patient with COVID-19 Ravinder Pal Singh, Nishkarsh Gupta, Tanudeep Kaur, Anju Gupta BMJ Case Reports.2021; 14(7): e244096. CrossRef
The double trouble: COVID-19 associated mucormycosis a focused review and future perspectives Arun Kumar Agnihotri, Monika Vij, Okezie I. Aruoma, Vipul D Yagnik, Theeshan Bahorun, Maria Elena Villamil, Godfred A. Menezes, Vineet Gupta Global Journal of Medical, Pharmaceutical, and Biomedical Update.2021; 16: 4. CrossRef
Epidemiology of Systemic Mycoses in the COVID-19 Pandemic María Guadalupe Frías-De-León, Rodolfo Pinto-Almazán, Rigoberto Hernández-Castro, Eduardo García-Salazar, Patricia Meza-Meneses, Carmen Rodríguez-Cerdeira, Roberto Arenas, Esther Conde-Cuevas, Gustavo Acosta-Altamirano, Erick Martínez-Herrera Journal of Fungi.2021; 7(7): 556. CrossRef
EFFICACY OF ENDOSCOPIC TOPICAL MITOMYCIN C APPLICATION IN CAUSTIC ESOPHAGEAL STRICTURES IN THE PEDIATRIC POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Marcelo Mochate FLOR, Igor Braga RIBEIRO, Diogo Turiani Hourneaux DE MOURA, Sérgio Barbosa MARQUES, Wanderley Marques BERNARDO, Eduardo Guimarães Hourneaux DE MOURA Arquivos de Gastroenterologia.2021; 58(2): 253. CrossRef
Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series Yudhyavir Singh, Venkata Ganesh, Shailendra Kumar, Nishant Patel, Richa Aggarwala, Kapil Dev Soni, Anjan Trikha Cureus.2021;[Epub] CrossRef
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature Deepak Garg, Valliappan Muthu, Inderpaul Singh Sehgal, Raja Ramachandran, Harsimran Kaur, Ashish Bhalla, Goverdhan D. Puri, Arunaloke Chakrabarti, Ritesh Agarwal Mycopathologia.2021; 186(2): 289. CrossRef
Mucormycosis and COVID‐19: An epidemic within a pandemic in India Lav Selarka, Suktara Sharma, Dinesh Saini, Sanjay Sharma, Amit Batra, Vishal T. Waghmare, Pratibha Dileep, Sanket Patel, Monarch Shah, Tejas Parikh, Prakash Darji, Amit Patel, Gaurav Goswami, Anand Shah, Sandeep Shah, Harsh Lathiya, Moksha Shah, Pranita S Mycoses.2021; 64(10): 1253. CrossRef
COVID-19 and mucormycosis superinfection: the perfect storm Jaffar A. Al-Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, Mohamad-Hani Temsah, Mazin Barry, Abbas Al Mutair, Ali A. Rabaan, Awadh Al-Omari, Raghavendra Tirupathi, Manaf AlQahtani, Salma AlBahrani, Kuldeep Dhama Infection.2021; 49(5): 833. CrossRef
COVID-19 Associated Rhino-Orbital Mucormycosis Complicated by Gangrenous and Bone Necrosis—A Case Report from Honduras Elsa Yolanda Palou, María Auxiliadora Ramos, Emec Cherenfant, Adoni Duarte, Itzel Carolina Fuentes-Barahona, Lysien I. Zambrano, Fausto Muñoz-Lara, Sandra Aracely Montoya-Ramirez, Alex Francisco Cardona-Ortiz, Jorge Alberto Valle-Reconco, Juan J. Monteneg Vaccines.2021; 9(8): 826. CrossRef
A rare case of knee joint mucormycosis with pathological fracture after COVID-19 infection Sergiu Andrei Iordache, Adrian Cursaru, Bogdan Şerban, Mihnea Ioan Gabriel Popa Romanian Journal of Orthopaedic Surgery and Traumatology.2021; 4(1): 9. CrossRef
Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World Valliappan Muthu, Shivaprakash M. Rudramurthy, Arunaloke Chakrabarti, Ritesh Agarwal Mycopathologia.2021; 186(6): 739. CrossRef
COVID-19-associated mucormycosis: Case report and systematic review Ahmet Dilek, Resat Ozaras, Sevket Ozkaya, Mustafa Sunbul, Elif Itir Sen, Hakan Leblebicioglu Travel Medicine and Infectious Disease.2021; 44: 102148. CrossRef
COVID-19 and mucormycosis in Latin America – An emerging concern Alfonso J. Rodriguez-Morales, Carlos S. Mamani-García, Janeth N. Nuñez-Lupaca, Darwin A. León-Figueroa, Mely Olarte-Durand, Robinson A. Yrene-Cubas, Diana M. Ticona, Sebastian Abanto-Urbano Travel Medicine and Infectious Disease.2021; 44: 102156. CrossRef
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients Maryam Roudbary, Sunil Kumar, Awanish Kumar, Lucia Černáková, Fatemeh Nikoomanesh, Célia F. Rodrigues Journal of Fungi.2021; 7(9): 720. CrossRef
A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update Faezeh Mohammadi, Milad Badri, Shapoor Safari, Nima Hemmat BMC Infectious Diseases.2021;[Epub] CrossRef
Mucormycosis: A manifestation in COVID-19 infection Abhishek Sharma, Gulnaz Bano, Abdul Malik Indian Journal of Pharmacy and Pharmacology.2021; 8(3): 189. CrossRef
A Review of Coronavirus Disease Covid-19 Swapnali Zore International Journal of Advanced Research in Science, Communication and Technology.2021; : 104. CrossRef
COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management Farah Yasmin, Hala Najeeb, Aisha Naeem, Kartik Dapke, Rachana Phadke, Muhammad Sohaib Asghar, Syed Muhammad Ismail Shah, Domenico De Berardis, Irfan Ullah Diseases.2021; 9(4): 65. CrossRef
COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping Salman Hussain, Harveen Baxi, Abanoub Riad, Jitka Klugarová, Andrea Pokorná, Simona Slezáková, Radim Líčeník, Abul Kalam Najmi, Miloslav Klugar International Journal of Environmental Research and Public Health.2021; 18(19): 10340. CrossRef
Rhino-orbital Mucormycosis as a complication of severe COVID-19 pneumonia Mohammed A. Alamin, Mohammed Abdulgayoom, Sushil Niraula, Elabbass Abdelmahmuod, Ashraf O. Ahmed, Mohammed I. Danjuma IDCases.2021; 26: e01293. CrossRef
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors Abanoub Riad, Alshaimaa Ahmed Shabaan, Julien Issa, Sally Ibrahim, Hatem Amer, Yossef Mansy, Islam Kassem, Amira Bisher Kassem, Hans-Peter Howaldt, Miloslav Klugar, Sameh Attia Journal of Fungi.2021; 7(10): 837. CrossRef
Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection Zeinab Mehrabi, Maryam Salimi, Kianoush Niknam, Farzaneh Mohammadi, Hesan Jelodari Mamaghani, Mohammad Reza Sasani, Mohammad Javad Ashraf, Amirhossein Salimi, Mohammad Hassan Zahedroozegar, Zohreh Erfani, Huban Atilla Case Reports in Ophthalmological Medicine.2021; 2021: 1. CrossRef
Mucormycosis infection in severe COVID‐19 patient with multiple underlying health conditions Zahra Heydarifard, Moslem Safaei, Sevrin Zadheidar, Soroush Ehsan, Nazanin Zahra Shafiei‐Jandaghi Clinical Case Reports.2021;[Epub] CrossRef
Invasive Fungal Infections Complicating COVID-19: A Narrative Review Giacomo Casalini, Andrea Giacomelli, Annalisa Ridolfo, Cristina Gervasoni, Spinello Antinori Journal of Fungi.2021; 7(11): 921. CrossRef
Coronavirus Disease 2019–Associated Invasive Fungal Infection John W Baddley, George R Thompson, Sharon C -A Chen, P Lewis White, Melissa D Johnson, M Hong Nguyen, Ilan S Schwartz, Andrej Spec, Luis Ostrosky-Zeichner, Brendan R Jackson, Thomas F Patterson, Peter G Pappas Open Forum Infectious Diseases.2021;[Epub] CrossRef
Manifestations and risk factors of COVID-19 and mucormycosis Jugal Sutradhar, Bapi Ray Sarkar Journal of Acute Disease.2021; 10(6): 221. CrossRef
Invasive Mucormycosis – An Enigma Anil Prasad, Minakshi Mishra, Kaushik Saha Cureus.2021;[Epub] CrossRef
Salix spp. Bark Hot Water Extracts Show Antiviral, Antibacterial, and Antioxidant Activities—The Bioactive Properties of 16 Clones Jenni Tienaho, Dhanik Reshamwala, Tytti Sarjala, Petri Kilpeläinen, Jaana Liimatainen, Jinze Dou, Anneli Viherä-Aarnio, Riikka Linnakoski, Varpu Marjomäki, Tuula Jyske Frontiers in Bioengineering and Biotechnology.2021;[Epub] CrossRef
Mucormycosis – resurgence of a deadly opportunist during COVID-19 pandemic: Four case reports Shalini Upadhyay, Tanisha Bharara, Manisha Khandait, Ankit Chawdhry, Bharat Bhushan Sharma World Journal of Clinical Cases.2021; 9(36): 11338. CrossRef
Mucormycosis following COVID19: clinical case and literature review Sofya N. Khostelidi, V.A. Zaytsev, E.V. Pelikh, E.V. Yashina, O.N. Rodionova, T.S. Bogomolova, Yu.L. Avdeenko, Nikolay N. Klimko Clinical Microbiology and Antimicrobial Chemotherapy.2021; 23(3): 255. CrossRef
COVID-19 associated mucormycosis (CAM) Manas Pustake, Purushottam Giri, Mohammad Arfat Ganiyani Journal of Family Medicine and Primary Care.2021; 10(12): 4619. CrossRef
Incidence, cumulative mortality and factors affecting the outcome of COVID-19-associated mucormycosis from Western India Archana Ajay Vare, Snehalata Yellambkar, Asma Farheen, Varsha Nandedkar, Swati S Bhombe, Rachana Shah Indian Journal of Ophthalmology.2021; 69(12): 3678. CrossRef
Hyo Keun Lee, M.D., Won Ki Bae, M.D., Woo Sun Rou, M.D., Tae Jun Song, M.D., Nam-Hoon Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D. and Mee Joo, M.D.*
Korean J Gastrointest Endosc 2010;41(6):385-389. Published online December 30, 2010
Ulcerative colitis is an idiopathic chronic inflammatory bowel disease that exclusively involves the colon. It is characterized by diffuse mucosal inflammation and a recurrent course of remission and relapse. Factors such as smoking, diet, genetic factors and miocrobial infection have all been suggested as causes of ulcerative colitis. One of the important issues in the treatment of ulcerative colitis is opportunistic infection associated with the usage of corticosteroid and immunosuppresant. In most cases, opportunistic cytomegalovirus infection after treatment with corticosteroid or immunosuppressant worsens the course of ulcerative colitis. However, cytomegalovirus infection is uncommon in immunocompetent patients and it is rare in immunocompetent patients with corticosteroid naive ulcerative colitis. We report here on a case in which an immunocompetent patient was newly diagnosed with ulcerative colitis and cytomegalovirus coinfection simultaneously. (Korean J Gastrointest Endosc 2010;41:385-389)
A 44-year-old female patient, with developmental disabilities and mental retardation after central nervous system (CNS) infection during infancy, presented with a complaint of severe abdominal distension and weight loss for the past two months. The patient was diagnosed with an intestinal pseudo-obstruction, based on radiological findings and an endoscopic finding of marked gaseous distension of the stomach and the small bowel without stenosis and mechanical obstruction. The patient had delayed gastrointestinal mobility. We report a case of an intestinal pseudo-obstruction accompanied with mental retardation after CNS infection. (Korean J Gastrointest Endosc 2008;37:288-292)